Valuation: Shivalik Rasayan Limited

Market Cap 4.68B 49.39M 44.09M 40.46M 36.81M 69.01M 70.38M 483M 195M 2.47B 185M 181M 7.79B P/E 2025
59.1x
P/E 2026 28.2x
Enterprise Value 5.56B 58.73M 52.43M 48.11M 43.77M 82.06M 83.69M 575M 232M 2.93B 220M 216M 9.27B EV / Sales 2025
3.4x
EV / Sales 2026 1.21x
Free-Float
46.1%
Yield 2025
0.08%
Yield 2026 0.23%
08-14 Shivalik Rasayan Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
07-23 Shivalik Rasayan Limited announced that it expects to receive INR 152.25 million in funding from Bishnoi Exports Private Limited, Growel Remedies Limited, Kim Ginnerup ApS and other investors CI
05-27 Shivalik Rasayan Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
05-27 Shivalik Rasayan Limited Announces Resignation of Sanjay Bansal as Non-Executive Director, Effective May 27, 2026 CI
05-27 Shivalik Rasayan Limited Recommends Final Dividend for the Financial Year 2025-26, Payable on or After October 15, 2026 CI
05-27 Shivalik Rasayan Ltd March-quarter consol net profit 45.3 million rupees RE
02-13 Shivalik Rasayan Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
11-14 Shivalik Rasayan Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
29/09/25 Shivalik Rasayan Limited Approves the Re-Designation of Mr. Ashwani Kumar Sharma as a Non-Executive, Non-Independent Director CI
12/08/25 Shivalik Rasayan Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
30/05/25 Shivalik Rasayan Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
29/05/25 Shivalik Rasayan Limited announces Annual dividend, payable on October 27, 2025 CI
23/04/25 Medicamen Biotech Limited announced that it has received INR 535.6816 million in funding from Kim Ginnerup ApS, Shivalik Rasayan Limited, VERALOGIX HOLDINGS LTD and other investors CI
1 day+2.41%
1 week-5.28%
Current month+1.50%
1 month-19.01%
3 months+17.83%
6 months+14.63%
Current year-14.57%
1 week 282.2
Extreme 282.2
320.95
1 month 282.2
Extreme 282.2
399.9
Current year 206
Extreme 206
437.9
1 year 206
Extreme 206
474.2
3 years 206
Extreme 206
873.6
5 years 206
Extreme 206
1,196.8
10 years 75.4
Extreme 75.4
1,196.8
Manager TitleAgeSince
Chief Executive Officer 64 16/11/2018
Director of Finance/CFO - 31/10/2001
Compliance Officer - 31/07/2017
Director TitleAgeSince
Chairman 62 22/02/2002
Director/Board Member 67 17/07/2003
Director/Board Member - 12/11/2018
Date Insider Type Main position Quantity % Market Cap. Importance
01/07/24 Don 21,500 0.1382%
26/06/24 Sell 108,500 0.6973%
Change 5-day change 1-year change 3-year change Capi.($)
+2.41%-5.28%-34.32%-56.23% 49.39M
-0.81%+2.44%+28.55%+29.06% 33.54B
-0.89%-0.42%+44.47%+49.81% 18.21B
+0.69%-1.53%-11.69%+32.01% 17.42B
-0.26%-2.15%-8.29%-15.63% 14.48B
+0.11%-.--%-.--%-.--% 12.96B
-1.01%-1.73%+4.63%+6.22% 10.85B
-1.53%-7.55%-5.76%+139.53% 9.06B
-0.22%-.--%-.--%-.--% 8.3B
+0.17%-0.25% - - 7.95B
Average +0.04%-0.95%+1.95%+20.53% 13.28B
Weighted average by Cap. +0.05%+0.17%+11.53%+28.37%

Financials

2025 2026
Net sales 3.1B 32.7M 29.19M 26.79M 24.37M 45.69M 46.6M 320M 129M 1.63B 123M 120M 5.16B 3.62B 38.2M 34.1M 31.29M 28.47M 53.37M 54.44M 374M 151M 1.91B 143M 140M 6.03B
Net income 167M 1.76M 1.57M 1.44M 1.31M 2.46M 2.51M 17.26M 6.96M 88.12M 6.62M 6.48M 278M 124M 1.31M 1.17M 1.07M 976K 1.83M 1.87M 12.82M 5.17M 65.45M 4.92M 4.81M 207M
Net Debt 768M 8.11M 7.24M 6.64M 6.04M 11.33M 11.55M 79.34M 31.98M 405M 30.43M 29.78M 1.28B 884M 9.34M 8.34M 7.65M 6.96M 13.05M 13.31M 91.4M 36.84M 467M 35.05M 34.31M 1.47B
Projected Income Statement - Annual - Shivalik Rasayan Limited
Logo Shivalik Rasayan Limited
Shivalik Rasayan Limited is an India-based company. The Company’s segments are engaged in agrochemicals, active pharma ingredients (API), and pharma formulation. It is the producer of Malathion Technical and Dimethoate Technical. Malathion Technical is a non-systemic, wide spectrum organophosphorus (OP) based contact insecticide. Dimethoate Technical is used in preparation of formulations used in the control of a range of insects and mites. It also manufactures organophosphorus-based insecticides and chemicals. It has a diverse product range and product mix in order to serve consumer requirements. The APIs are being developed and manufactured in the niche area of oncology, ARVs, cardiovascular, metabolic disorders and immunology. It offers solutions from product selection to development to commercialization for a range of oncology and non-oncology products. The Company’s oncology products include Azacitidine, Busulfan, Bortezomib, and various others.
Employees
342
Date Price Change Volume
03/11/26 ₹304.00 +2.41% 11,256
02/11/26 ₹296.85 -0.88% 4,837
30/10/26 ₹299.50 -4.13% 7,486
29/10/26 ₹312.40 -1.01% 2,904
28/10/26 ₹315.60 -1.67% 915
  1. Stock Market
  2. Stocks
  3. SHIVALIK Stock